Evidence mapPaperPMID 41623754Full record

ArticleBioinformation2025

Assessment of lixisenatide-induced nephropathy in chick embryos: Implications for prevention of diabetic kidney disease.

Amit Kumar Srivastava, Aishwarya Srivastava, Rohini Srivastava, Swati Yadav, Jyoti Batra, Yogesh Yadav

Abstract read
In one paragraph

Article in Bioinformation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Amit Kumar SrivastavaDepartment of Anatomy, Government Medical College, Datia, Madhya Pradesh, India.
Aishwarya SrivastavaDepartment of Biochemistry, Naraina Medical College and Research Centre, Kanpur, Uttar Pradesh, India.
Rohini SrivastavaDepartment Pathology, Naraina Medical College and Research Centre, Kanpur, Uttar Pradesh, India.
Swati YadavDepartment of Anatomy, Santosh Medical College and Hospital, Ghaziabad, Uttar Pradesh, India.
Jyoti BatraDean Research, Central Research Facility, Santosh Deemed to be University, Ghaziabad, Uttar Pradesh, India.
Yogesh YadavDepartment of Anatomy, Saraswathi Institute of Medical Sciences, Hapur, Uttar Pradesh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic kidney disease (DKD) is a major cause of end-stage renal disease and the direct renal effects of GLP-1 receptor agonists remain underexplored. Using a hyperglycemic chick embryo model (n=120), we evaluated dose-dependent nephroprotective effects of lixisenatide. Hyperglycemia induced renal hypertrophy, histological injury, oxidative stress, inflammation and apoptosis. Lixisenatide, particularly at high doses, significantly ameliorated these changes, normalizing kidney-to-body ratios and reducing MDA, TNF-α and caspase-3 activity. Thus, we show that lixisenatide directly preserves renal structure and function independent of systemic metabolic control.

Indexed as

chick embryodiabetic kidney diseaseGLP-1 receptor agonistLixisenatidenephroprotectionoxidative stress

Identifiers

PMID41623754
PMCPMC12859325

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.